Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment
Trial details
- Registry ID
- NCT06590090
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentNCT06590090 | XBIT | Phase 2 | Not yet recruiting | 2027-01-15Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |